Phase I Study of Binimetinib and Palbociclib In Patients With Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
The purpose of this phase I study is to evaluate the safety and efficacy of binimetinib and Palbociclib, in patients with operable KRAS-positive solid tumors, including pancreatic cancer.
Study ID: I 797920
Trial Phase: Phase I
Trial Sponsor: Roswell Park Cancer Institute
Therapies Used in This Trial: Binimetinib, Palbociclib